SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001564590-20-052747
Filing Date
2020-11-10
Accepted
2020-11-10 08:00:58
Documents
52
Period of Report
2020-09-30

Document Format Files

Seq Description Document Type Size
1 10-Q prld-10q_20200930.htm 10-Q 2151610
2 EX-3.1 prld-ex31_234.htm EX-3.1 51836
3 EX-3.2 prld-ex32_235.htm EX-3.2 297302
4 EX-31.1 prld-ex311_9.htm EX-31.1 17950
5 EX-31.2 prld-ex312_8.htm EX-31.2 17962
6 EX-32.1 prld-ex321_7.htm EX-32.1 9575
7 EX-32.2 prld-ex322_6.htm EX-32.2 9650
  Complete submission text file 0001564590-20-052747.txt   5593532

Data Files

Seq Description Document Type Size
8 XBRL INSTANCE DOCUMENT prld-20200930.xml EX-101.INS 775784
9 XBRL TAXONOMY EXTENSION SCHEMA prld-20200930.xsd EX-101.SCH 34298
10 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE prld-20200930_cal.xml EX-101.CAL 22380
11 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE prld-20200930_def.xml EX-101.DEF 158518
12 XBRL TAXONOMY EXTENSION LABEL LINKBASE prld-20200930_lab.xml EX-101.LAB 289341
13 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE prld-20200930_pre.xml EX-101.PRE 234074
Mailing Address 200 POWDER MILL ROAD WILMINGTON DE 19803
Business Address 200 POWDER MILL ROAD WILMINGTON DE 19803 (302) 547-3768
Prelude Therapeutics Inc (Filer) CIK: 0001678660 (see all company filings)

IRS No.: 811384762 | State of Incorp.: DE | Fiscal Year End: 0331
Type: 10-Q | Act: 34 | File No.: 001-39527 | Film No.: 201299673
SIC: 2834 Pharmaceutical Preparations